Disease Info Card

Reticuloendothelial Hyperplasia

Information about Reticuloendothelial Hyperplasia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Reticuloendothelial Hyperplasia

Most recent studies have shown that Reticuloendothelial Hyperplasia shares some biological mechanisms with anemia, avian-leukosis, cell-transformation-neoplastic, fowlpox, hairy-cell-leukemia, histiocytosis-langerhans-cell, infective-disorder, leukemia, lymphatic-diseases, lymphoma, lymphoproliferative-disorders, malignant-paraganglionic-neoplasm, marek-disease, neoplasms, poultry-diseases, reticuloendotheliosis-avian, retroviridae-infections, sarcoma, tumor-virus-infections, virus-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Reticuloendothelial Hyperplasia, and have been seen in publications frequently: Cell Cycle, Cell Death, Cell Killing, Cell Proliferation, Cytolysis, Glycosylation, Hatching, Humoral Immune Response, Immune Response, Localization, Lymphocyte Proliferation, Pathogenesis, Phagocytosis, Reverse Transcription, Secretion, Translation, Transport, Viral Replication, Viral Transcription, Virulence

Quite a number of genes have been found to play important roles in Reticuloendothelial Hyperplasia, such as ALB, C3, CALM2, CENPV, CS, HLA-E, IFNG, IL2, JUN, MYC, NFKB1, NT5E, POMC, REL, RELA, RELB, SEC14L2, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.